1.Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA2DS2 -VASc Score 0–1: A Korean Multi-Center Cohort
Moonki JUNG ; Kyeongmin BYEON ; Ki-Woon KANG ; Yae Min PARK ; You Mi HWANG ; Sung Ho LEE ; Eun-Sun JIN ; Seung-Young ROH ; Jin Seok KIM ; Jinhee AHN ; So-Ryoung LEE ; Eue-Keun CHOI ; Min-soo AHN ; Eun Mi LEE ; Hwan-Cheol PARK ; Ki Hong LEE ; Min KIM ; Joon Hyouk CHOI ; Jum Suk KO ; Jin Bae KIM ; Changsoo KIM ; Gregory Y.H. LIP ; Seung Yong SHIN ;
Yonsei Medical Journal 2022;63(10):892-901
Purpose:
Atrial fibrillation (AF) patients with low to intermediate risk, defined as non-gender CHA2DS2-VASc score of 0–1, are still at risk of stroke. This study verified the usefulness of ABCD score [age (≥60 years), B-type natriuretic peptide (BNP) or N-terminal pro-BNP (≥300 pg/mL), creatinine clearance (<50 mL/min/1.73 m2 ), and dimension of the left atrium (≥45 mm)] for stroke risk stratification in non-gender CHA2DS2-VASc score 0–1.
Materials and Methods:
This multi-center cohort study retrospectively analyzed AF patients with non-gender CHA2DS2-VASc score 0–1. The primary endpoint was the incidence of stroke with or without antithrombotic therapy (ATT). An ABCD score was validated.
Results:
Overall, 2694 patients [56.3±9.5 years; female, 726 (26.9%)] were followed-up for 4.0±2.8 years. The overall stroke rate was 0.84/100 person-years (P-Y), stratified as follows: 0.46/100 P-Y for an ABCD score of 0; 1.02/100 P-Y for an ABCD score ≥1. The ABCD score was superior to non-gender CHA2DS2-VASc score in the stroke risk stratification (C-index=0.618, p=0.015; net reclassification improvement=0.576, p=0.040; integrated differential improvement=0.033, p=0.066). ATT was prescribed in 2353 patients (86.5%), and the stroke rate was significantly lower in patients receiving non-vitamin K antagonist oral anticoagulant (NOAC) therapy and an ABCD score ≥1 than in those without ATT (0.44/100 P–Y vs. 1.55/100 P-Y; hazard ratio=0.26, 95% confidence interval 0.11–0.63, p=0.003).
Conclusion
The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0–1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0–1.
2.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 5. Post-cardiac arrest care
Young-Min KIM ; Kyung Woon JEUNG ; Won Young KIM ; Yoo Seok PARK ; Joo Suk OH ; Yeon Ho YOU ; Dong Hoon LEE ; Minjung Kathy CHAE ; Yoo Jin JEONG ; Min Chul KIM ; Eun Jin HA ; Kyoung Jin HWANG ; Won-Seok KIM ; Jae Myung LEE ; Kyoung-Chul CHA ; Sung Phil CHUNG ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Ai-Rhan Ellen KIM ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S41-S64
3.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 5. Post-cardiac arrest care
Young-Min KIM ; Kyung Woon JEUNG ; Won Young KIM ; Yoo Seok PARK ; Joo Suk OH ; Yeon Ho YOU ; Dong Hoon LEE ; Minjung Kathy CHAE ; Yoo Jin JEONG ; Min Chul KIM ; Eun Jin HA ; Kyoung Jin HWANG ; Won-Seok KIM ; Jae Myung LEE ; Kyoung-Chul CHA ; Sung Phil CHUNG ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Ai-Rhan Ellen KIM ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S41-S64
4.Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016.
Deog Young KIM ; Yun Hee KIM ; Jongmin LEE ; Won Hyuk CHANG ; Min Wook KIM ; Sung Bom PYUN ; Woo Kyoung YOO ; Suk Hoon OHN ; Ki Deok PARK ; Byung Mo OH ; Seong Hoon LIM ; Kang Jae JUNG ; Byung Ju RYU ; Sun IM ; Sung Ju JEE ; Han Gil SEO ; Ueon Woo RAH ; Joo Hyun PARK ; Min Kyun SOHN ; Min Ho CHUN ; Hee Suk SHIN ; Seong Jae LEE ; Yang Soo LEE ; Si Woon PARK ; Yoon Ghil PARK ; Nam Jong PAIK ; Sam Gyu LEE ; Ju Kang LEE ; Seong Eun KOH ; Don Kyu KIM ; Geun Young PARK ; Yong Il SHIN ; Myoung Hwan KO ; Yong Wook KIM ; Seung Don YOO ; Eun Joo KIM ; Min Kyun OH ; Jae Hyeok CHANG ; Se Hee JUNG ; Tae Woo KIM ; Won Seok KIM ; Dae Hyun KIM ; Tai Hwan PARK ; Kwan Sung LEE ; Byong Yong HWANG ; Young Jin SONG
Brain & Neurorehabilitation 2017;10(Suppl 1):e11-
“Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” is the 3rd edition of clinical practice guideline (CPG) for stroke rehabilitation in Korea, which updates the 2nd edition published in 2014. Forty-two specialists in stroke rehabilitation from 21 universities and 4 rehabilitation hospitals and 4 consultants participated in this update. The purpose of this CPG is to provide optimum practical guidelines for stroke rehabilitation teams to make a decision when they manage stroke patients and ultimately, to help stroke patients obtain maximal functional recovery and return to the society. The recent two CPGs from Canada (2015) and USA (2016) and articles that were published following the 2nd edition were used to develop this 3rd edition of CPG for stroke rehabilitation in Korea. The chosen articles' level of evidence and grade of recommendation were decided by the criteria of Scotland (2010) and the formal consensus was derived by the nominal group technique. The levels of evidence range from 1++ to 4 and the grades of recommendation range from A to D. Good Practice Point was recommended as best practice based on the clinical experience of the guideline developmental group. The draft of the developed CPG was reviewed by the experts group in the public hearings and then revised. “Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” consists of ‘Chapter 1; Introduction of Stroke Rehabilitation’, ‘Chapter 2; Rehabilitation for Stroke Syndrome, ‘Chapter 3; Rehabilitation for Returning to the Society’, and ‘Chapter 4; Advanced Technique for Stroke Rehabilitation’. “Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” will provide direction and standardization for acute, subacute and chronic stroke rehabilitation in Korea.
Canada
;
Consensus
;
Consultants
;
Humans
;
Korea*
;
Practice Guidelines as Topic
;
Rehabilitation*
;
Scotland
;
Specialization
;
Stroke*
5.Comparison of volume-controlled and pressure-controlled ventilation in the Trendelenburg position for gynecological laparoscopic surgery.
Kyung Mi KIM ; Hyun Soo MOON ; Soo Kyung LEE ; Eun Young KIM ; Sangjun LEE ; Woon Suk HWANG ; Sung Wook JANG ; Seung Ju KIM
Anesthesia and Pain Medicine 2015;10(4):278-283
BACKGROUND: Minimal invasive gynecologic surgery usually requires pneumoperitoneum and Trendelenburg positioning, which results in adverse effects on respiratory and hemodynamic parameters. The aim of this study was to investigate the effects of volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) introduced sequentially in patients who underwent gynecological laparoscopy on respiratory mechanics, cardiovascular responses, and gas exchange. METHODS: Forty patients who were scheduled for gynecologic laparoscopic surgery were enrolled. Baseline ventilation of their lungs was performed with VCV with a tidal volume (TV) of 8 ml/kg ideal body weight (IBW). Forty minutes after pneumoperitoneum and Trendelenburg positioning, the ventilation mode was changed to PCV, and airway pressure was set to provide a TV of 8 ml/kg IBW without exceeding 35 cmH2O. Respiratory mechanics and hemodynamic and gas exchange parameters were recorded at 10 minutes after induction, 30 minutes after CO2 pneumoperitoneum and Trendelenburg positioning, 30 minutes after PCV, and 30 minutes after desufflation and supine position. RESULTS: After pneumoperitoneum and Trendelenburg positioning, there were significant increases in systolic blood pressure, diastolic blood pressure, central venous pressure, peak airway pressure (PAP), mean airway pressure (Pmean), whereas lung compliance and PaO2 significantly decreased. The decrease in PAP and increases of Pmean, lung compliance and PaO2 were observed during PCV compared with VCV (P < 0.05). There were no differences in hemodynamic parameters between VCV and PCV. CONCLUSIONS: Our results demonstrated that PCV may be an effective method of ventilation during gynecologic laparoscopy in terms of improved oxygenation and minimizing adverse respiratory mechanics.
Blood Pressure
;
Central Venous Pressure
;
Female
;
Gynecologic Surgical Procedures
;
Head-Down Tilt*
;
Hemodynamics
;
Humans
;
Ideal Body Weight
;
Laparoscopy*
;
Lung
;
Lung Compliance
;
Oxygen
;
Pneumoperitoneum
;
Respiratory Mechanics
;
Supine Position
;
Tidal Volume
;
Ventilation*
6.Celiac Disease in a Predisposed Subject (HLA-DQ2.5) with Coexisting Graves' Disease.
In Kyoung HWANG ; Seon Hye KIM ; Unjoo LEE ; Sang Ouk CHIN ; Sang Youl RHEE ; Seungjoon OH ; Jeong Taek WOO ; Sung Woon KIM ; Young Seol KIM ; Suk CHON
Endocrinology and Metabolism 2015;30(1):105-109
Celiac disease is an intestinal autoimmune disorder, triggered by ingestion of a gluten-containing diet in genetically susceptible individuals. The genetic predisposition is related to human leukocyte antigen (HLA) class II genes, especially HLA-DQ2-positive patients. The prevalence of celiac disease has been estimated to be ~1% in Europe and the USA, but it is rarer and/or underdiagnosed in Asia. We report a case of celiac disease in a predisposed patient, with a HLA-DQ2 heterodimer, and Graves' disease that was treated successfully with a gluten-free diet. A 47-year-old woman complained of persistent chronic diarrhea and weight loss over a 9 month period. Results of all serological tests and stool exams were negative. However, the patient was found to carry the HLA DQ2 heterodimer. Symptoms improved after a gluten-free diet was initiated. The patient has been followed and has suffered no recurrence of symptoms while on the gluten-free diet. An overall diagnosis of celiac disease was made in a genetically predisposed patient (HLA-DQ2 heterodimer) with Graves' disease.
Asia
;
Celiac Disease*
;
Diagnosis
;
Diarrhea
;
Diet
;
Diet, Gluten-Free
;
Eating
;
Europe
;
Female
;
Genes, MHC Class II
;
Genetic Predisposition to Disease
;
Graves Disease*
;
Humans
;
Leukocytes
;
Middle Aged
;
Prevalence
;
Recurrence
;
Serologic Tests
;
Weight Loss
7.Acromegaly due to a Macroinvasive Plurihormonal Pituitary Adenoma and a Rectal Carcinoid Tumor.
Sang Ouk CHIN ; Jin Kyung HWANG ; Sang Youl RHEE ; Suk CHON ; Seungjoon OH ; Misu LEE ; Natalia S PELLEGATA ; Sung Woon KIM
Endocrinology and Metabolism 2015;30(3):389-394
A macroinvasive pituitary adenoma with plurihormonality usually causes acromegaly and hyperprolactinemia, and also accompanies with neurologic symptoms such as visual disturbances. However, its concurrent presentation with a rectal carcinoid tumor is rarely observed. This study reports the history, biochemical, colonoscopic and immunohistochemical results of a 48-year-old female with acromegaly and hyperprolactinemia. Despite the large size and invasive nature of the pituitary adenoma to adjacent anatomical structures, she did not complain of any neurologic symptoms such as visual disturbance or headache. Immunohistochemical staining of the surgical specimen from the pituitary adenoma revealed that the tumor cells were positive for growth hormone (GH), prolactin (PRL), and thyroid stimulating hormone (TSH). Staining for pituitary-specific transcription factor-1 (Pit-1) was shown to be strongly positive, which could have been possibly contributing to the plurihormonality of this adenoma. Colonoscopy found a rectal polyp that was identified to be a carcinoid tumor using immunohistochemical staining. A macroinvasive pituitary adenoma with concomitant rectal carcinoid tumor was secreting GH, PRL, and TSH, which were believed to be in association with over-expression of Pit-1. This is the first case report of double primary tumors comprising a plurihormonal pituitary macroadenoma and rectal carcinoid tumor.
Acromegaly*
;
Adenoma
;
Carcinoid Tumor*
;
Colonoscopy
;
Female
;
Growth Hormone
;
Headache
;
Humans
;
Hyperprolactinemia
;
Middle Aged
;
Neurologic Manifestations
;
Pituitary Neoplasms*
;
Polyps
;
Prolactin
;
Thyrotropin
8.Practice patterns in the management of threatened preterm labor in Korea: A multicenter retrospective study.
Han Sung HWANG ; Sung Hun NA ; Sung Eun HUR ; Soon Ae LEE ; Kyung A LEE ; Geum Joon CHO ; Kwan Young OH ; Chan Hee JIN ; Seung Mi LEE ; Jae Eun SHIN ; Kyo Hoon PARK ; Ji Young LIM ; Suk Joo CHOI ; Joon Ho LEE ; Sae Kyung CHOI ; Jae Yoon SHIM ; Yun Sung JO ; Gyu Yeon CHOI ; Young Han KIM ; Ki Cheol KIL ; Jong Woon KIM ; Dong Wook KWAK ; Yun Dan KANG ; Young Ju KIM
Obstetrics & Gynecology Science 2015;58(3):203-209
OBJECTIVE: This study aimed to examine clinical practice patterns in the management of pregnant women admitted with threatened preterm labor (TPL) in Korea. METHODS: Data from women admitted with a diagnosis of TPL were collected from 22 hospitals. TPL was defined as regular uterine contractions with or without other symptoms such as pelvic pressure, backache, increased vaginal discharge, menstrual-like cramps, bleeding/show and cervical changes. Data on general patient information, clinical characteristics at admission, use of tocolytics, antibiotics, and corticosteroids, and pregnancy outcomes were collected using an online data collections system. RESULTS: A total of 947 women with TPL were enrolled. First-line tocolysis was administered to 822 (86.8%) patients. As a first-line tocolysis, beta-agonists were used most frequently (510/822, 62.0%), followed by magnesium sulfate (183/822, 22.3%), calcium channel blockers (91/822, 11.1%), and atosiban (38/822, 4.6%). Of the 822 women with first-line tocolysis, second-line tocolysis were required in 364 (44.3%). Of 364 with second-line, 199 had third-line tocolysis (37.4%). Antibiotics were administered to 29.9% of patients (284/947) with single (215, 22.7%), dual (26, 2.7%), and triple combinations (43, 4.5%). Corticosteroids were administered to 420 (44.4%) patients. Betamethasone was administered to 298 patients (71.0%), and dexamethasone was administered to 122 patients (29.0%). CONCLUSION: Practice patterns in the management of TPL in Korea were quite various. It is needed to develop standardized practice guidelines for TPL management.
Adrenal Cortex Hormones
;
Anti-Bacterial Agents
;
Back Pain
;
Betamethasone
;
Calcium Channel Blockers
;
Dexamethasone
;
Diagnosis
;
Female
;
Humans
;
Korea
;
Magnesium Sulfate
;
Muscle Cramp
;
Obstetric Labor, Premature*
;
Physician's Practice Patterns
;
Pregnancy
;
Pregnancy Outcome
;
Pregnant Women
;
Premature Birth
;
Retrospective Studies*
;
Tocolysis
;
Tocolytic Agents
;
Uterine Contraction
;
Vaginal Discharge
9.Change in Somatostatinergic Tone of Acromegalic Patients according to the Size of Growth Hormone-Producing Pituitary Tumors.
Sang Ouk CHIN ; Suk CHON ; You Cheol HWANG ; In Kyung JEONG ; Seungjoon OH ; Sung Woon KIM
Journal of Korean Medical Science 2013;28(12):1774-1780
The aim of this study was to investigate the relationship between somatostatinergic tone (SST) and the size of growth hormone (GH)-producing pituitary tumors. GH levels of 29 patients with newly diagnosed acromegaly were measured using a 75-gram oral glucose tolerance test (OGTT), an insulin tolerance test (ITT), and an octreotide suppression test (OST). Differences between GH levels during the ITT and the OGTT (DeltaGH(IO)), and between the OGTT and the OST at the same time point (DeltaGH(OS)) were compared according to the size of the tumor and the response pattern to the OST. DeltaGH(IO) of macroadenomas (n=22) was non-significantly higher than those of microadenomas while DeltaGH(OS) of macroadenomas were significantly higher than those of microadenomas. According to further analyses of macroadenomas based on the response pattern to the OST, GH levels during the ITT were significantly higher in non-responders. DeltaGH(OS) showed near-significant differences between responders and non-responders. In conclusion, as the size of the pituitary tumor increases, the effect of glucose on SST appears to be attenuated. Macroadenomas that are non-responders to the OST possess a portion of GH secretion exceeding the range of regulation by SST.
Acromegaly/*diagnosis/*pathology
;
Adenoma/drug therapy/*pathology
;
Adult
;
Aged
;
Antineoplastic Agents, Hormonal/therapeutic use
;
Female
;
Glucose Tolerance Test
;
Human Growth Hormone/*blood/secretion
;
Humans
;
Insulin/blood
;
Insulin-Like Growth Factor I/analysis
;
Male
;
Middle Aged
;
Octreotide/therapeutic use
;
Pituitary Neoplasms/drug therapy/*pathology
10.Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes.
Sang Ouk CHIN ; Jin Kyung HWANG ; Sang Youl RHEE ; Suk CHON ; You Cheol HWANG ; Seungjoon OH ; Kyu Jeung AHN ; Ho Yeon CHUNG ; Jeong Taek WOO ; Sung Woon KIM ; Young Seol KIM ; Ja Heon KANG ; In Kyung JEONG
Diabetes & Metabolism Journal 2013;37(5):365-374
BACKGROUND: Intima-media thickness (IMT) of the carotid arteries is known to have a positive correlation with the risk of cardiovascular disease. This study was designed to identify risk factors affecting the progression of carotid IMT in patients with type 2 diabetes mellitus (T2DM). METHODS: Patients with newly diagnosed T2DM with carotid IMT measurements were enrolled, and their clinical data and carotid IMT results at baseline and 2 years later were compared. RESULTS: Of the 171 patients, 67.2% of males and 50.8% of females had abnormal baseline IMT of the left common carotid artery. At baseline, systolic blood pressure, body mass index and smoking in male participants, and fasting plasma glucose and glycated hemoglobin levels in females were significantly higher in patients with abnormal IMT than in those with normal IMT. Low density lipoprotein cholesterol (LDL-C) levels in males and high density lipoprotein cholesterol (HDL-C) levels in females at the 2-year follow-up were significantly different between the nonprogression and the progression groups. Reduction of the United Kingdom Prospective Diabetes Study (UKPDS) 10-year coronary heart disease (CHD) risk score after 2 years was generally higher in the nonprogression group than the progression group. CONCLUSION: LDL-C levels in males and HDL-C levels in females at the 2-year follow-up were significantly different between participants with and without progression of carotid IMT. Furthermore, a reduction in the UKPDS 10-year CHD risk score appeared to delay the advancement of atherosclerosis. Therefore, the importance of establishing the therapeutic goal of lipid profiles should be emphasized to prevent the progression of carotid IMT in newly diagnosed T2DM patients.
Atherosclerosis
;
Blood Pressure
;
Blood Glucose
;
Body Mass Index
;
Cardiovascular Diseases
;
Carotid Arteries
;
Carotid Artery, Common
;
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL
;
Coronary Disease
;
Diabetes Mellitus, Type 2
;
Fasting
;
Female
;
Follow-Up Studies*
;
Hemoglobin A, Glycosylated
;
Humans
;
Lipoproteins
;
Male
;
Risk Factors*
;
Smoking

Result Analysis
Print
Save
E-mail